Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients (Q33577482)

28 July 2017

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients (English)

1 reference

28 July 2017

0 references

Michelle DallaPiazza

1

1 reference

28 July 2017

Valerianna K Amorosa

2

1 reference

28 July 2017

Russell Localio

3

1 reference

28 July 2017

Jay R Kostman

4

1 reference

28 July 2017

Vincent Lo Re

5

1 reference

28 July 2017

13 May 2010

1 reference

28 July 2017

BMC Infectious Diseases

1 reference

28 July 2017

10

1 reference

28 July 2017

116

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

start time

13 May 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-10-116

0 references

cites work

Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

CD4+ count-guided interruption of antiretroviral treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

Screening for hepatitis C virus in human immunodeficiency virus-infected individuals

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

Antiretroviral drugs and liver injury

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876168

Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-116

Hepatic steatosis as an emerging cause of cirrhosis in HIV-infected patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20465840

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20465840

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-10-116

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference